Immunis
Biotechnology, Von Karman Ave, Irvine, , 92612, California, 18301, United States, 1-10 Employees
Phone Number: +12*********
Who is IMMUNIS
Immunis Inc. is a private biotechnology company focused on the development of treatments for age-related and disease-related immune deficits. Immunis has developed a novel method to grow ...
Read More
-
Headquarters: 18301 Von Karman Ave, Irvine, California, 92612, United States
-
Date Founded: 2019
-
Employees: 1-10
-
Revenue: $250 Million to $500 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 541714 |
Show More
Immunis Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Immunis
Answer: Immunis's headquarters are located at Von Karman Ave, Irvine, , 92612, California, 18301, United States
Answer: Immunis's phone number is +12*********
Answer: Immunis's official website is https://immunisbiomedical.com
Answer: Immunis's revenue is $250 Million to $500 Million
Answer: Immunis's SIC: 8731
Answer: Immunis's NAICS: 541714
Answer: Immunis has 1-10 employees
Answer: Immunis is in Biotechnology
Answer: Immunis contact info: Phone number: +12********* Website: https://immunisbiomedical.com
Answer: Immunis Inc. is a private biotechnology company focused on the development of treatments for age-related and disease-related immune deficits. Immunis has developed a novel method to grow human cells for clinical use, and direct them to become highly pure populations of defined cells that secrete factors which benefit immune system development, modulation, and health. With age, every person experiences a reduction of factors which benefit immune system development, modulation, and health; our technology allows replacement of those factors. Our investigational product is all natural, all human, and represents a perfectly balanced set of immune modulators in naturally occurring relevant physiological concentrations. Immunis' first clinical trial is a Phase 1/2a study of the effectiveness of STEM in treating muscle atrophy, which every person experiences with age.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month